Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shao-Rong Yu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
AI Zheng = Aizheng = Chinese Journal of Cancer|November 10, 2009
Circulating tumor cells and individualized chemotherapyShao-Rong Yu, Jia Wei, Xiao-Ping Qian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 6, 2018
Advances of circular RNAs in carcinomaXiao-Yue Xu, Lei-Lei Zhou, Chen Yu, et al.
Biochemical and Biophysical Research Communications|October 17, 2015
LXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activationYing Wu, Dan-dan Yu, Yong Hu, et al.
Journal of Cellular Physiology|September 8, 2018
MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathwayJin Gao, Shao-Rong Yu, Yuan Yuan, et al.
Oncology Reports|April 26, 2016
Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarrayYing Wu, Dan-Dan Yu, Yong Hu, et al.
Anti-Cancer Drugs|February 13, 2016
Liver X receptor as a drug target for the treatment of breast cancerYing Wu, Dan-Dan Yu, Da-Li Yan, et al.
Cancer Biology & Medicine|January 23, 2015
Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKIGuo-Hao Xia, Yun Zeng, Ying Fang, et al.
Biochemical and Biophysical Research Communications|January 22, 2016
WITHDRAWN: The long non-coding RNA, LINC00635-001, sensitizes EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activationYing Wu, Dan-Dan Yu, Yong Hu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
AI Zheng = Aizheng = Chinese Journal of Cancer|November 10, 2009
Circulating tumor cells and individualized chemotherapyShao-Rong Yu, Jia Wei, Xiao-Ping Qian, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 6, 2018
Advances of circular RNAs in carcinomaXiao-Yue Xu, Lei-Lei Zhou, Chen Yu, et al.
Biochemical and Biophysical Research Communications|October 17, 2015
LXR ligands sensitize EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activationYing Wu, Dan-dan Yu, Yong Hu, et al.
Journal of Cellular Physiology|September 8, 2018
MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathwayJin Gao, Shao-Rong Yu, Yuan Yuan, et al.
Oncology Reports|April 26, 2016
Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarrayYing Wu, Dan-Dan Yu, Yong Hu, et al.
Anti-Cancer Drugs|February 13, 2016
Liver X receptor as a drug target for the treatment of breast cancerYing Wu, Dan-Dan Yu, Da-Li Yan, et al.
Cancer Biology & Medicine|January 23, 2015
Effect of EGFR-TKI retreatment following chemotherapy for advanced non-small cell lung cancer patients who underwent EGFR-TKIGuo-Hao Xia, Yun Zeng, Ying Fang, et al.
Biochemical and Biophysical Research Communications|January 22, 2016
WITHDRAWN: The long non-coding RNA, LINC00635-001, sensitizes EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activationYing Wu, Dan-Dan Yu, Yong Hu, et al.
Pageof 1